CCFP priority topic 11 of 105
Breast Lump on the CCFP exam
3 key features, the mistakes that cost marks, and a practice question.
Checked by a Canadian family physician, MD, CCFP. Updated October 20, 2026.
What the exam tests
Key features
The CFPC’s 3 key features for Breast Lump. Each one below has how the exam asks it, the common mistakes and the approach.
Practice question
Try one before you read
A real case from the bank, in the new short-menu format. Answer it first. Then read the key features.
Key feature 1 of 3
Risk and screening
For a healthy woman worried about breast cancer, judge her risk and explain screening honestly.
CFPC skill Clinical reasoning, selectivity, patient-centred approachPhase History, diagnosis, treatmentSources Canadian Task Force on Preventive Health Care, Choosing Wisely Canada
On the exam
A healthy 16-year-old whose mother had breast cancer at 38 asks about her own risk. Expect a short menu (pick several from a list).
Pick the history that changes her risk.
Common mistakes
At 16, asking about breastfeeding, children or dense breasts: adult items that change nothing. Chasing antiperspirants, bras, soy or caffeine: none causes breast cancer.
Approach
- Take the family history on both sides: who had breast or ovarian cancer, and at what age. Ask about a known gene change in the family.
- Ask about radiation to the chest at a young age, and about her own past breast disease.
- Name the risks she can change: alcohol, weight gain after menopause, too little exercise, and long use of hormone therapy.
- Gene testing starts with a relative who had cancer. Defer predictive testing in a minor: nothing changes for years, and the choice should be hers as an adult.
- The 2024 Task Force draft covers average and moderately raised risk. Moderate means a 12 to 20% lifetime risk, from dense breasts or one first-degree or two second-degree relatives diagnosed after 50.
- A known gene change, a strong family history, past breast cancer or symptoms fall outside the draft. Refer to genetics or high-risk screening, or work up the symptom.
- Offering mammography: give benefits and harms in absolute numbers and decide together. The CFPC took mammography off its Choosing Wisely list in May 2024; the choice rests on her values.
| Draft position | Strength | |
|---|---|---|
| 40 to 49 | Suggests not screening every woman. Offer a mammogram every 2 to 3 years if she wants one after being informed. | Conditional, very low certainty |
| 50 to 74 | Suggests a mammogram every 2 to 3 years, after a shared decision. | Conditional, very low certainty |
| 75 and older | Suggests not screening. | Conditional, very low certainty |
| Dense breasts or a moderate family history | No extra MRI or ultrasound. | Conditional, very low certainty |
Key feature 2 of 3
Working up a lump
When a breast lump appears, match the tests to age and findings, and keep the patient informed.
CFPC skill Selectivity, clinical reasoning, patient-centred approach, professionalismPhase Diagnosis, treatment, follow-up, investigation
On the exam
A rubbery, mobile lump at 16, or a firm disc under a 5-year-old's nipple. Expect a short menu (pick several from a list).
Pick the first test, or none.
Common mistakes
A mammogram, needle or excision because a relative had cancer. In a child, that disc is a breast bud. Too little: discharging a lump with no plan to recheck it.
Approach
- Ask how long the lump has been there, whether it changes with periods or grows, and about pain, nipple discharge or skin change.
- Examine both breasts, both armpits and above the collarbones. A hard, fixed or irregular lump, or one pulling the skin, raises concern at any age.
- Match imaging to the patient's age and findings. A suspicious lump goes on to tissue diagnosis and a surgeon.
- A normal scan does not clear a lump that feels suspicious.
- A child with a disc under the areola has a breast bud. Do not needle or remove it. Look for early puberty: a growth spurt, pubic hair, body odour.
- Give a name and number to call while results are pending, and say when you will call. If a referral date never comes, phone the clinic yourself.
Key feature 3 of 3
After the diagnosis
In a woman with known breast cancer, watch for treatment harms and spread, and link her to support.
CFPC skill Clinical reasoning, selectivity, patient-centred approachPhase Diagnosis, treatment, hypothesis generation, history, follow-upSources Choosing Wisely Canada, Health Canada
On the exam
A woman two years on tamoxifen has new back pain and spotting. Expect a short menu (pick several from a list).
Pick what to ask, then what to test.
Common mistakes
Ordering tumour markers and body scans for a well survivor to be safe. Or calling her new back pain a strain, and the spotting a normal period.
Approach
- Well, with no new symptoms: skip blood tests and body scans hunting for spread. Often they do not help her live longer or better, and they add worry.
- At each visit, ask about new bone pain, cough or breathlessness, headache, weight loss and belly pain. A new symptom earns a test aimed at it.
- In a patient with bone spread, tamoxifen can raise calcium in its first few weeks. With known bone spread, check it then. Check it any time she is thirsty, confused or constipated.
- Tamoxifen raises the risk of uterine cancer and of clots in the legs and lungs. Investigate abnormal vaginal bleeding promptly.
- Tamoxifen needs a liver enzyme, CYP2D6, to work. Where possible, avoid paroxetine, which blocks it, for her hot flashes or mood.
- Letrozole and other aromatase inhibitors thin bone and raise fracture risk. Check bone health and cholesterol during treatment.
- Ask about mood, fear of the cancer coming back, body image, sex and money. Link her to a cancer support line, a peer group or a social worker.
| Treatment or problem | Watch for | What you do |
|---|---|---|
| Tamoxifen | Uterine cancer, clots in the legs or lungs | Investigate vaginal bleeding promptly. Ask about leg swelling and breathlessness. |
| Aromatase inhibitor, such as letrozole | Bone loss and fracture, joint pain, high cholesterol | Check bone health and cholesterol during treatment. For women after menopause only. |
| Spread to bone | Bone pain, high calcium | Test the painful site. With known bone spread, check calcium in the first weeks of tamoxifen. |
Flashcards
Answer it first, then check.
KF 1Under the 2024 Task Force draft, who is screened with mammography, and how often?
Women 50 to 74, every 2 to 3 years after a shared decision. At 40 to 49, only if she wants it once informed. Source: Canadian Task Force on Preventive Health Care
KF 1She is 52 with dense breasts and no other risk. Add MRI or ultrasound?
No. The 2024 draft suggests against extra MRI or ultrasound for dense breasts alone. Source: Canadian Task Force on Preventive Health Care
KF 1A healthy 16-year-old asks for the family breast cancer gene test. What do you advise?
Defer it. A result changes nothing for years, and the choice should be hers as an adult.
KF 2A hard, fixed lump pulls the skin at 30. Wait a cycle and recheck?
No. A hard, fixed or tethered lump needs prompt imaging and tissue diagnosis at any age.
KF 2A firm disc under one areola in a 5-year-old girl. Do you needle it?
No. It is a breast bud. Look for other signs of early puberty instead.
KF 3She is on tamoxifen and wants paroxetine for hot flashes. Is it a good choice?
Avoid it where possible. It blocks the liver enzyme that tamoxifen needs and may weaken it. Source: Health Canada
KF 3Vaginal spotting on tamoxifen, a year after her last period. What next?
Investigate it promptly. Tamoxifen raises the risk of uterine cancer. Source: Health Canada
KF 3A well survivor with no symptoms asks for a body scan to be sure. Order it?
No. Hunting for spread in a well survivor often does not help and adds worry. Test new symptoms. Source: Choosing Wisely Canada
FAQ
Which breast screening guideline should I know?
The Task Force's 2024 draft. Its site marks it a draft and archived, and posts no final version. Provincial programs set their own rules, so know your own province too.
Does a woman with a lump wait for her next screening mammogram?
No. Screening advice is for women without symptoms, and the 2024 draft leaves out anyone with them. A lump needs its own work-up now, starting with the right imaging.
Do tumour markers help with a breast lump?
No. They do not diagnose a breast lump at any age. In a well survivor they are not routine either. Let a survivor's new symptoms decide which test you order.
Can she take letrozole before menopause?
No. The monograph lists premenopausal women as a contraindication. If her periods stopped after chemotherapy, hormone blood tests must confirm she is past menopause before treatment and regularly in its first 6 months.
Sources
Written from the CFPC Assessment Objectives and Canadian guidelines first. Checked by a Canadian family physician, MD, CCFP.
Last reviewed October 20, 2026For exam study. Not advice for a patient in front of you.
- Assessment Objectives for Certification in Family Medicine, 2nd editionCollege of Family Physicians of Canada · 2020
- Published prevention guidelinesCanadian Task Force on Preventive Health Care
- Choosing Wisely recommendationsChoosing Wisely Canada
- Drug Product DatabaseHealth Canada